{
  "trial_id": "NCT02543723",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race/ethnicity, education level, employment status, marital status, type of cancer, stage of cancer, previous chemotherapy treatments, baseline medication adherence, comorbidities, socioeconomic status, geographic location, access to healthcare, baseline cognitive function, baseline psychiatric status, type of oral chemotherapeutic agent, duration of current OCA therapy, baseline health-related quality of life, baseline physical functioning, baseline medication side effects, baseline support system.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race/ethnicity"
        ],
        [
          "Region of Enrollment",
          "geographic location"
        ],
        [
          "Cancer Health Literacy Test (CHLT-30)",
          "education level"
        ],
        [
          "Self-efficacy for Appropriate Medication Use Scale (SEAMS)",
          "baseline medication adherence"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male"
      ],
      "remaining_candidate_features": [
        "employment status",
        "marital status",
        "type of cancer",
        "stage of cancer",
        "previous chemotherapy treatments",
        "comorbidities",
        "socioeconomic status",
        "access to healthcare",
        "baseline cognitive function",
        "baseline psychiatric status",
        "type of oral chemotherapeutic agent",
        "duration of current OCA therapy",
        "baseline health-related quality of life",
        "baseline physical functioning",
        "baseline medication side effects",
        "baseline support system"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Cancer Type, Stage of Cancer, Current Cycle of OCA, Baseline Medication Adherence, Socioeconomic Status, Education Level, Access to Healthcare,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)",
        "Cancer Health Literacy Test (CHLT-30)",
        "Self-efficacy for Appropriate Medication Use Scale (SEAMS)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Cancer Type",
        "Stage of Cancer",
        "Current Cycle of OCA",
        "Baseline Medication Adherence",
        "Socioeconomic Status",
        "Education Level",
        "Access to Healthcare"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Cancer Diagnosis, OCA Type, Number of Cycles, Baseline Adherence, Performance Status, Comorbidities,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Cancer Health Literacy Test (CHLT-30)",
        "Self-efficacy for Appropriate Medication Use Scale (SEAMS)"
      ],
      "remaining_candidate_features": [
        "Cancer Diagnosis",
        "OCA Type",
        "Number of Cycles",
        "Baseline Adherence",
        "Performance Status",
        "Comorbidities"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, education level, marital status, employment status, income level, health insurance status, cancer diagnosis, OCA type, duration of OCA treatment, number of comorbidities, Charlson Comorbidity Index, Eastern Cooperative Oncology Group (ECOG) performance status, baseline medication adherence, quality of life, anxiety and depression scores.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Cancer Health Literacy Test (CHLT-30)",
        "Self-efficacy for Appropriate Medication Use Scale (SEAMS)"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "education level",
        "marital status",
        "employment status",
        "income level",
        "health insurance status",
        "cancer diagnosis",
        "OCA type",
        "duration of OCA treatment",
        "number of comorbidities",
        "Charlson Comorbidity Index",
        "Eastern Cooperative Oncology Group (ECOG) performance status",
        "baseline medication adherence",
        "quality of life",
        "anxiety and depression scores."
      ]
    }
  }
}